Southeastern Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,288,500
Closed -$216M 28
2019
Q2
$216M Sell
1,288,500
-739,045
-36% -$102M 3.54% 13
2019
Q1
$297M Sell
2,027,545
-119,837
-6% -$17.4M 4.28% 11
2018
Q4
$287M Sell
2,147,382
-147,677
-6% -$24.2M 4.1% 10
2018
Q3
$437M Sell
2,295,059
-694,346
-23% -$128M 5.25% 9
2018
Q2
$498M Sell
2,989,405
-129,719
-4% -$20.8M 5.57% 8
2018
Q1
$525M Buy
3,119,124
+821,738
+36% +$138M 6.43% 5
2017
Q4
$376M Buy
+2,297,386
New +$412M 4.65% 10

Other funds holding AGN

Southeastern Asset Management's AGN Position: Q3 2019 in Review

Southeastern Asset Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,288,500 shares — an estimated $216M sold.

Southeastern Asset Management first reported a position in AGN in Q4 2017 and held it in 7 quarters. The position peaked at $525M in Q1 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Southeastern Asset Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Southeastern Asset Management sold 1,288,500 Allergan plc shares in Q3 2019, an estimated $216M.
  • Southeastern Asset Management first reported a position in Allergan plc in Q4 2017 and held it in 7 quarters.
  • Southeastern Asset Management's Allergan plc position peaked at $525M in Q1 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Southeastern Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.